Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

SangStat's Thymoglobulin nearing phase III trials completion

Aug. 9, 1996

Peptech issued U.S. patent for GMDP as antiinflammatory agent

Aug. 9, 1996

American Home Products claims rapamycin compounds

Aug. 9, 1996

Immunostimulant series described by Takeda

Aug. 9, 1996

Biogal describes cyclosporin emulsions

July 26, 1996

Rapamycin esters from American Home Products

July 26, 1996

Immunoregulatory peptides with special binding properties

July 26, 1996

HSV proteins as immune resonse regulators

July 26, 1996

Ono's Ono-4057 shows immunosuppressive effects in preclinical trials

July 19, 1996

SmithKline Beecham's DTaP vaccine receives unanimous advisory committee approval

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...